Examination of Left Atrial Fibrosis Using MRI

This study is enrolling participants by invitation only.
Sponsor:
Information provided by (Responsible Party):
University of Pittsburgh
ClinicalTrials.gov Identifier:
NCT01233674
First received: November 2, 2010
Last updated: November 21, 2011
Last verified: November 2011
  Purpose

This study evaluates images obtained from a standard clinical cardiac MRI for evidence of fibrosis.


Condition
Fibrosis

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Examination of Left Atrial Fibrosis Using MRI

Further study details as provided by University of Pittsburgh:

Estimated Enrollment: 100
Study Start Date: March 2011
Estimated Study Completion Date: December 2015
Estimated Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)
Groups/Cohorts
patients referred for standard of care MRI

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

all patients referred for standard of care MRI

Criteria

Inclusion Criteria:

  • 18+ years of age
  • being scheduled for a standard of care MRI

Exclusion Criteria:

- patient unable to provide informed consent

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01233674

Locations
United States, Pennsylvania
UPMC CVI
Pittsburgh, Pennsylvania, United States, 15213
Sponsors and Collaborators
University of Pittsburgh
  More Information

No publications provided

Responsible Party: University of Pittsburgh
ClinicalTrials.gov Identifier: NCT01233674     History of Changes
Other Study ID Numbers: 08120067
Study First Received: November 2, 2010
Last Updated: November 21, 2011
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Fibrosis
Pathologic Processes

ClinicalTrials.gov processed this record on April 17, 2014